1971
Combined Live Measles, Mumps, Rubella Vaccine
Search citation statements
Paper Sections
Select...
23
1
0
0
Citation Types
1
4
0
0
Year Published
1971
2024
Publication Types
Select...
13
11
Relationship
0
24
Authors
Journals
Cited by 24 publications
(5 citation statements)
References 2 publications
1
4
0
0
Smart CitationsHow this paper cites the one you are viewing
“…Of 163 reported cases in the United States in 1972,44.2% of the patients were age 5--9, 16.6% age 0-4, and 16.0% age 10--14. The remainder of cases were scattered throughout all other age groups. A similar age distribution was seen in 76 cases of aseptic meningitis reported in the same period. Mumps-associated deaths in 158 cases from 1966 to 1971 were distributed by age as follows: 38% over age 40,22.2% age 5--9 yr, and 19% age 0-4 yr.…”
Section: Age
supporting
confidence: 81%
Smart CitationsHow this paper cites the one you are viewing
“…Of 163 reported cases in the United States in 1972,44.2% of the patients were age 5--9, 16.6% age 0-4, and 16.0% age 10--14. The remainder of cases were scattered throughout all other age groups. A similar age distribution was seen in 76 cases of aseptic meningitis reported in the same period. Mumps-associated deaths in 158 cases from 1966 to 1971 were distributed by age as follows: 38% over age 40,22.2% age 5--9 yr, and 19% age 0-4 yr.…”
Section: Age
supporting
confidence: 81%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…These candidate LAMVs produced no disease in macaques and provided protection from challenge with wild-type measles virus (70,71). The LAMV licensed in 1963 frequently produced fever and rash (72,73). Further passage in tissue culture yielded the current LAMVs that cause fever and rash in less than 10% of immunized children (74,75).…”
Section: Measles Vaccines
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…MV is an antigenically invariant pathogen where acute infection elicits protective immunity in convalescent persons. This allowed the licensing of a live virus attenuated vaccine via passage of a human isolate through tissue culture [97]. Vaccination provides life-long immunity after two inoculations during childhood.…”
Section: Measles
mentioning
confidence: 99%
